z-logo
Premium
GFAP alternative splicing regulates glioma cell–ECM interaction in a DUSP4‐dependent manner
Author(s) -
Bodegraven Emma J.,
Asperen Jessy V.,
Sluijs Jacqueline A.,
Deursen Coen B. J.,
Strien Miriam E.,
Stassen Oscar M. J. A.,
Robe Pierre A. J.,
Hol Elly M.
Publication year - 2019
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fj.201900916r
Subject(s) - glioma , glial fibrillary acidic protein , extracellular matrix , cancer research , rna splicing , biology , alternative splicing , microbiology and biotechnology , chemistry , gene , immunohistochemistry , immunology , biochemistry , rna , messenger rna
Gliomas are the most common primary brain tumors. Their highly invasive character and the heterogeneity of active oncogenic pathways within single tumors complicate the development of curative therapies and cause poor patient prognosis. Glioma cells express the intermediate filament protein glial fibrillary acidic protein (GFAP), and the level of its alternative splice variant GFAP‐δ , relative to its canonical splice variant GFAP‐α , is higher in grade IV compared with lower‐grade and lower malignant glioma. In this study we show that a high GFAP‐δ/α ratio induces the expression of the dual‐specificity phosphatase 4 (DUSP4) in focal adhesions. By focusing on pathways up‐ and downstream of DUSP4 that are involved in the cell‐extracellular matrix interaction, we show that a high GFAP‐δ/α ratio equips glioma cells to better invade the brain. This study supports the hypothesis that glioma cells with a high GFAP‐δ/α ratio are highly invasive and more malignant cells, thus making GFAP alternative splicing a potential therapeutic target.—Van Bodegraven, E. J., van Asperen, J. V., Sluijs, J. A., van Deursen, C. B. J., van Strien, M. E., Stassen, O. M. J. A., Robe, P. A. J., Hol, E. M. GFAP alternative splicing regulates glioma cell–ECM interaction in a DUSP4‐dependent manner. FASEB J. 33, 12941–12959 (2019). www.fasebj.org

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here